Efficacy of carbetocin for preventing postpartum bleeding after cesarean section in twin pregnancy

References

• World Health Organization. WHO Guidelines for the management of postpartum haemorrhage and Retained Placenta; 2009 [cited 2018 Mar 15]. Available from: http://whqlibdoc.who.int/publications/2009/9789241598514_eng.
   Google Scholar
• Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333.
   PubMed Web of Science ®Google Scholar
• Ramanathan G, Arulkumaran S. Postpartum haemorrhage. J Obstet Gynaecol Can. 2006;28(11):967–973.
   PubMedGoogle Scholar
• ACOG Practice Bulletin. Postpartum Hemorrhage. Clinical management guidelines for obstetrician gynecologists. 2017;130(4):e168–e185.
   Google Scholar
• Royal College of Obstetricians and Gynaecologists. Prevention and treatment of postpartum haemorrhage. Royal College of Obstetricians and Gynaecologists Green-Top Guideline. 2016;(52)e107–e149.
   Google Scholar
• Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009;31(10):980–993.
   PubMedGoogle Scholar
• Amsalem H, Aldrich CJ, Oskamp M, et al. Postpartum uterine response to oxytocin and carbetocin. J Reprod Med. 2014;59(3–4):167–173.
   PubMed Web of Science ®Google Scholar
• Mehrabadi A, Liu S, Bartholomew S, et al. Temporal trends in postpartum hemorrhage and severe postpartum hemorrhage in Canada from 2003 to 2010. J Obstet Gynaecol Can. 2014;36(1):21–33.
   PubMedGoogle Scholar
• Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010;202(4):353.e1–353.e6.
   PubMed Web of Science ®Google Scholar
• Ford JB, Roberts CL, Simpson JM, et al. Increased postpartum hemorrhage rates in Australia. Int J Gynecol Obstet. 2007;98(3):237–243.
   PubMed Web of Science ®Google Scholar
• Lutomski JE, Byrne BM, Devane D, et al. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG. 2012;119(3):306–314.
   PubMed Web of Science ®Google Scholar
• Cameron MJ. Definitions, vital statistics and risk factors: an overview. In: Arulkumaran S, Karosi M, Keith LG, Lalonde AB, B-Lynch C, et al., editors. A Comprehensive textbook of postpartum haemorrhage. 2nd edition, Chapter 17. London: Sapiens Publishing Ltd; 2012.
   Google Scholar
• Gizzo S, Patrelli TS, Di Gangi SD, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci. 2013;20(9):1011–1019.
   PubMed Web of Science ®Google Scholar
• Engström T, Barth T, Melin P, et al. Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol. 1998;355(2–3):203–210.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther. 1992;52(1):60–67.
   PubMed Web of Science ®Google Scholar
• Sweeney G, Holbrook AM, Levine M, et al. Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in non pregnant women. Curr Ther Res. 1990;47:528–540.
   Web of Science ®Google Scholar
• Ferring. Inc. product Monograph: Duratocin (carbetocin Injection). [cited 2018 Apr 20]. Available from: http://www.ferring.ca/media/1065/duratocin-product-monograph-march-2006-english.pdf.
   Google Scholar
• Boucher M, Horbay GL, Griffin P, et al. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol. 1998;18(3):202–207.
   PubMedGoogle Scholar
• Dansereau J, Joshi AK, Helewa ME, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol. 1999;180(3 Pt 1):670–676.
   PubMed Web of Science ®Google Scholar
• Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet. 2009;280(5):707–712.
   PubMed Web of Science ®Google Scholar
• Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG. 2010;117(8):929–936.
   PubMed Web of Science ®Google Scholar
• Triopon G, Goron A, Agenor J, et al. Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin. Gynecol Obstet Fertil. 2010;38(12):729–734. French.
   PubMedGoogle Scholar
• Cordovani D, Balki M, Farine D, et al. Carbetocin at elective cesarean delivery: a randomized controlled trial to determine the effective dose. Can J Anesth. 2012;59(8):751–757.
   PubMed Web of Science ®Google Scholar
• De Bonis M, Torricelli M, Leoni L, et al. Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage. J Matern Fetal Neonatal Med. 2012;25(6):732–735.
   PubMed Web of Science ®Google Scholar
• Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;4:CD005457.
   Google Scholar
• Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2011. Natal Vital Stat Rep. 2013;62(1):1–69.
   Google Scholar
• Conde-Agudelo A, Belizán JM, Lindmark G. Maternal morbidity and mortality associated with multiple gestations. Obstet Gynecol. 2000;95(6 Pt 1):899–904.
   PubMed Web of Science ®Google Scholar
• Demetz J, Clouqueur E, D’Haveloose A, et al. Systematic use of carbetocin during cesarean delivery of multiple pregnancies: a before-and-after study. Arch Gynecol Obstet. 2013;287(5):875–880.
   PubMed Web of Science ®Google Scholar
• Seow KM, Chen KH, Wang PH, et al. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in infertile women with twin pregnancy undergoing elective cesarean delivery. Taiwan J Obstet Gynecol. 2017;56(3):273–275.
   PubMed Web of Science ®Google Scholar
• Stafford I, Dildy GA, Clark SL, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199(5):519.e1–519.e7.
   PubMed Web of Science ®Google Scholar
• Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113(8):919–924.
   PubMed Web of Science ®Google Scholar
• Patel A, Goudar SS, Geller SE, et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynecol Obstet. 2006;93(3):220–224.
   PubMed Web of Science ®Google Scholar
• Jin B, Du Y, Zhang F, et al. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2016;29(3):400–407.
   PubMed Web of Science ®Google Scholar
• Nirmala K, Zainuddin AA, Ghani NA, et al. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery. J Obstet Gynaecol Res. 2009;35(1):48–54.
   PubMed Web of Science ®Google Scholar
• Askar AA, Ismail MT, El-Ezz AA, et al. Carbetocin versus syntometrine in the management of third stage of labor following vaginal delivery. Arch Gynecol Obstet. 2011;284(6):1359–1365.
   PubMed Web of Science ®Google Scholar
• Higgins L, Mechery J, Tomlinson AJ. Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin? J Obstet Gynaecol. 2011;31(8):732–739.
   PubMedGoogle Scholar
• Ortiz SR, Perez RA, Hernandez RS, et al. WITHDRAWN: Carbetocin versus oxytocin for prevention of postpartum hemorrhage: a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol. 2014.
   PubMedGoogle Scholar